Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial disparities in access to alternative donor allografts persist in the era of "donors for all".
Fingrut WB, Gyurkocza B, Davis E, Flynn J, Chinapen S, Naputo KA, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos E, Perales MA, Ponce DM, Shaffer BC, Sauter CS, Tamari R, Young JW, Scaradavou A, Politikos I, Barker JN. Fingrut WB, et al. Among authors: sauter cs. Blood Adv. 2022 Oct 25;6(20):5625-5629. doi: 10.1182/bloodadvances.2022007814. Blood Adv. 2022. PMID: 35675518 Free PMC article. No abstract available.
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.
Lin RJ, Hilden PD, Elko TA, Dahi PB, Shahrokni A, Jakubowski AA, Perales MA, Sauter CS, Castro-Malaspina HR, Barker JN, Shaffer BC, Tamari R, Papadopoulos EB, Maloy MA, Korc-Grodzicki B, Giralt SA. Lin RJ, et al. Among authors: sauter cs. Blood Adv. 2019 Jan 8;3(1):12-20. doi: 10.1182/bloodadvances.2018028241. Blood Adv. 2019. PMID: 30606722 Free PMC article.
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.
Barker JN, Devlin SM, Naputo KA, Skinner K, Maloy MA, Flynn L, Anagnostou T, Avecilla ST, Scaradavou A, Cho C, Dahi PB, Giralt SA, Gyurkocza B, Hanash AM, Hsu K, Jakubowski AA, Papadopoulos EB, Peled JU, Perales MA, Sauter CS, Shah GL, Shaffer BC, Tamari R, Young JW, Roshal M, O'Reilly RJ, Ponce DM, Politikos I. Barker JN, et al. Among authors: sauter cs. Blood Adv. 2020 Dec 8;4(23):6064-6076. doi: 10.1182/bloodadvances.2020003371. Blood Adv. 2020. PMID: 33290545 Free PMC article.
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.
Lahoud OB, Devlin SM, Maloy MA, Roeker LE, Dahi PB, Ponce DM, Gyurkocza B, Koehne G, Young JW, Castro-Malaspina HR, Barker JN, Papadopoulos EB, Jakubowski AA, Zelenetz AD, Mato AR, Giralt SA, Perales MA, Sauter CS. Lahoud OB, et al. Among authors: sauter cs. Blood Adv. 2021 Jul 27;5(14):2879-2889. doi: 10.1182/bloodadvances.2020003726. Blood Adv. 2021. PMID: 34297048 Free PMC article.
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.
Shouval R, Fein JA, Cho C, Avecilla ST, Ruiz J, Tomas AA, Sanchez-Escamilla M, Flores NC, Yáñez L, Barker JN, Dahi P, Giralt SA, Geyer AI, Gyurkocza B, Jakubowski AA, Lin RJ, O'Reilly RJ, Papadopoulos EB, Politikos I, Ponce DM, Sauter CS, Scordo M, Shaffer B, Shah GL, Sullivan JP, Tamari R, van den Brink MRM, Young JW, Nagler A, Devlin S, Shimoni A, Perales MA. Shouval R, et al. Among authors: sauter cs. Blood Adv. 2022 Mar 8;6(5):1525-1535. doi: 10.1182/bloodadvances.2021004319. Blood Adv. 2022. PMID: 34507354 Free PMC article.
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients.
Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. Sauter CS, et al. Biol Blood Marrow Transplant. 2014 Mar;20(3):354-60. doi: 10.1016/j.bbmt.2013.11.029. Epub 2013 Dec 4. Biol Blood Marrow Transplant. 2014. PMID: 24315843 Free PMC article. Clinical Trial.
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies.
Sauter CS, Chou JF, Papadopoulos EB, Perales MA, Jakubowski AA, Young JW, Scordo M, Giralt S, Castro-Malaspina H. Sauter CS, et al. Leuk Lymphoma. 2014 Dec;55(12):2739-47. doi: 10.3109/10428194.2014.894185. Epub 2014 Mar 20. Leuk Lymphoma. 2014. PMID: 24528216 Free PMC article. Clinical Trial.
Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era.
Mussetti A, Devlin SM, Castro-Malaspina HR, Barker JN, Giralt SA, Zelenetz AD, Sauter CS, Perales MA. Mussetti A, et al. Among authors: sauter cs. Bone Marrow Transplant. 2015 Oct;50(10):1293-1298. doi: 10.1038/bmt.2015.156. Epub 2015 Jul 6. Bone Marrow Transplant. 2015. PMID: 26146802 Free PMC article.
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.
Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, Goldberg JD, Perales MA, Ponce DM, Sauter CS, Maloy MA, Herman DY, Klimek V, Young JW, O'Reilly RJ, Giralt SA, Castro-Malaspina H. Tamari R, et al. Among authors: sauter cs. Biol Blood Marrow Transplant. 2015 Dec;21(12):2106-2114. doi: 10.1016/j.bbmt.2015.07.010. Epub 2015 Jul 14. Biol Blood Marrow Transplant. 2015. PMID: 26187863 Free PMC article.
233 results